Abstract
The majority of patients with pancreatic cancer present with disease that is unresectable due to local invasion. This article reviews the evidence (or lack thereof) that chemoradiation therapy (CRT) helps these patients in four areas: survival, tumor downstaging, palliation of obstructive symptoms, and pain control. We believe that CRT allows a small percentage of patients with locally advanced disease to undergo potentially curative resection while providing effective palliative treatment.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 109-113 |
| Number of pages | 5 |
| Journal | HPB |
| Volume | 7 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 2005 |
| Externally published | Yes |
Keywords
- Chemoradiation
- Neoadjuvant
- Palliation
- Pancreatic cancer
- Pancreaticoduodenectomy
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Fingerprint Dive into the research topics of 'The role of chemoradiation therapy in locally advanced pancreatic cancer'. Together they form a unique fingerprint.
Cite this
White, R. R., Reddy, S., & Tyler, D. S. (2005). The role of chemoradiation therapy in locally advanced pancreatic cancer. HPB, 7(2), 109-113. https://doi.org/10.1080/13651820510028963a